Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG)
Advances in Clinical and Experimental Medicine · 15.10.2026 · 35 (10) · 1725-1734
DOI: 10.17219/acem/215822 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Advances in Clinical and Experimental Medicine, online erschienen am 15.10.2026. Verfasst von Elżbieta Iskierka-Jażdżewska und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital, Łódź, Poland. Hauptthemen laut MEDLINE: Adenine, Piperidines, Leukemia, Lymphocytic, Chronic, B-Cell, Mutation. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital, Łódź, Poland.
- Department of Hematology, Medical University of Lodz, Poland.
- Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Poland.
- Department of Tumor Biology and Genetics, Medical University of Warsaw, Poland.
- Department of Hematology, University Hospital in Rzeszów, Poland.
- Department of Hematology, Internal Medicine and Bone Marrow Transplantation, Clinical Hospital of the Ministry of Internal Affairs and Administration with the Warmia-Mazury Oncology Centre in Olsztyn, Poland.
Zitieren
APA
Iskierka-Jażdżewska, E., Zielonka, K., Puła, B., Chudy, A., Kustra, M., Brodacka, B., Subocz, E., Urbanowicz, A., Wiśniewska-Organek, D., Dąbrowska-Iwanicka, A., Kozak-Białek, A., Leończuk, N., Łuksza, E., Markiewicz, M., Morawska, M., Oller, M., Radwański, S., Szeremet, A., Tomczak, W., …, & Jamroziak, K. (2026). Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG). Advances in Clinical and Experimental Medicine, 35(10), 1725-1734. https://doi.org/10.17219/acem/215822
Vancouver
Iskierka-Jażdżewska E, Zielonka K, Puła B, Chudy A, Kustra M, Brodacka B, et al. Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG). Advances in Clinical and Experimental Medicine. 2026;35(10):1725-1734. doi:10.17219/acem/215822
BibTeX
@article{IskierkaJadewska2026,
author = {Iskierka-Jażdżewska, Elżbieta and Zielonka, Klaudia and Puła, Bartosz and Chudy, Agnieszka and Kustra, Monika and Brodacka, Beata and Subocz, Edyta and Urbanowicz, Alina and Wiśniewska-Organek, Dominika and Dąbrowska-Iwanicka, Anna and Kozak-Białek, Aneta and Leończuk, Natalia and Łuksza, Ewa and Markiewicz, Mirosław and Morawska, Marta and Oller, Marta and Radwański, Sławomir and Szeremet, Agnieszka and Tomczak, Waldemar and Górecki, Tomasz and Stokłosa, Tomasz and Jamroziak, Krzysztof},
title = {Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG)},
journal = {Advances in Clinical and Experimental Medicine},
year = {2026},
volume = {35},
number = {10},
pages = {1725--1734},
doi = {10.17219/acem/215822}
}
EUVIMED